Obstructive sleep apnoea-hypopnoea (OSAH) causes excessive daytime sleepiness,
impairs quality-of-life, and increases cardiovascular disease and road traffic accident risks …

Patients with obstructive sleep apnea (OSA) frequently present with symptoms of depression
and anxiety. The objective of this study is to determine if treatment with positive airway …

Excessive daytime sleepiness (EDS) and neurocognitive dysfunction are commonly
observed in patients with obstructive sleep apnea (OSA), and these daytime functional …

Excessive daytime sleepiness (EDS) is a major symptom of obstructive sleep apnoea (OSA),
defined as the inability to stay awake during the day. Its clinical descriptors remain elusive …

Excessive daytime sleepiness (EDS) is a symptom of obstructive sleep apnea (OSA) that
resolves under treatment with continuous positive airway pressure (CPAP). In some patients …

To date, continuous positive airway pressure (CPAP) is the most effective intervention in the
treatment of obstructive sleep apnoea, but adherence to this treatment is often less than …

Rationale Mandibular advancement devices (MADs) are used to treat obstructive sleep
apnoea-hypopnoea syndrome (OSAHS) but evidence is lacking regarding their clinical and …

Study Objective: To determine the long-term clinical effectiveness and safety of
maxillomandibular advancement (MMA) for the treatment of moderate to severe obstructive …

We evaluated factors associated with subjective and objective sleepiness at baseline and
after 6 months of continuous positive airway pressure (CPAP) therapy in patients with …

Objective Most patients with resistant hypertension (RH) have obstructive sleep apnea
(OSA). We aimed to determine the impact of OSA and continuous positive airway pressure …